For Immediate Release
October 3, 2005
For more information, contact:
Mike Shefky at mshefky@sitcancer.org
sitc 20th ANNIVERSARY ANNUAL MEETING
TO BE HELD NOVEMBER 10 - 13 IN ALEXANDRIA, VA
Milwaukee - The International Society for Biological Therapy of Cancer (sitc) will showcase, explore and critically evaluate the most promising advances in biological cancer therapies at its 20th Anniversary Annual Meeting on November 10-13, 2005 at the Hilton Alexandria Mark Center in Alexandria, Virginia.
This year's meeting features keynote addresses by two respected investigators, as well as the inaugural Richard V. Smalley, MD Memorial Award and Lectureship. James Allison, MD of the Memorial Sloan-Kettering Cancer Center will present Checkpoint Blockade in Tumor Immunotherapy on Friday, November 11 and Garret M. Hampton, PhD of the Genomics Institute will present Large-scale Genomic Methods to Dissect Cancer Phenotypes on Saturday, November 12. On Sunday, November 13 the winner of the first-ever Richard V. Smalley, MD Memorial Award, Steven A. Rosenberg, MD, PhD, will give a lectureship in biological therapy to the Annual Meeting attendants.
20th Anniversary Annual Meeting session topics include:
The 20th Anniversary Annual Meeting will also have expanded viewing times for over 130 scientific posters from authors around the globe. The ever-popular poster discussion session returns again this year. This session features discussion around some of this year's best poster presentations and is led by top sitc Annual Meeting faculty members.
In conjunction with the Annual Meeting, the sitc is also holding two concurrent programs, the Primer on Tumor Immunology and Biological Therapy and the Cancer Vaccine Clinical Trials Workshop, on Thursday, November 10. The Primer is a general education program featuring a series of basic science, industry and clinical presentations related to the biological therapy of cancer. The Workshop is a one-day event organized by the Cancer Vaccine Clinical Trials Working Group (CVCTWG), a joint initiative of the Cancer Vaccine Cosortium (CVC) of the Sabin Vaccine Institute and sitc with the purpose of helping move cancer vaccines through the clinical development process more efficiently and expeditiously, accelerating their development and general patient access.
On Saturday, November 12, the sitc will announce its Presidential Award winner. The Presidential Award is presented to the author of the year's best abstract submitted by students, post doctoral fellows-in-training or Junior Faculty with three or less years on staff. Along with the award, the winner will receive a check for $1,000 from the sitc.
Founded in 1984, the International Society for Biological Therapy of Cancer (sitc) is an organization of clinicians, researchers, students, post-doctoral fellows, and allied health professionals dedicated to improving cancer patient outcomes by advancing the development and application of biological therapy through interaction, innovation and leadership.
###
EDITOR'S NOTE: Members of the media are encouraged to attend the 20th Anniversary Annual Meeting free of charge by presenting their press credentials at the sitc Registration Desk located in the Hilton Alexandria Mark Center.
